| Period Ending |
Nov 30, 2014 |
Aug 31, 2014 |
May 31, 2014 |
Feb 28, 2014 |
| Total Revenue |
41 |
43 |
– |
– |
| Cost of Revenue |
– |
– |
– |
– |
|
| Gross Profit |
41 |
43 |
– |
– |
|
|
Operating Expenses |
|
Research Development |
– |
– |
– |
– |
|
Selling General and Administrative |
1,145 |
1,342 |
7,187 |
95 |
|
Non Recurring |
– |
– |
– |
– |
|
Others |
8 |
5 |
– |
– |
|
|
|
Total Operating Expenses |
– |
– |
– |
– |
|
|
| Operating Income or Loss |
(1,113) |
(1,304) |
(7,298) |
(95) |
|
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
(12) |
21 |
9 |
(9) |
|
Earnings Before Interest And Taxes |
(1,125) |
(1,283) |
(7,290) |
(104) |
|
Interest Expense |
– |
– |
0 |
(1) |
|
Income Before Tax |
(1,125) |
(1,283) |
(7,290) |
(104) |
|
Income Tax Expense |
– |
– |
(6) |
2 |
|
Minority Interest |
– |
– |
– |
– |
|
|
|
Net Income From Continuing Ops |
(1,125) |
(1,283) |
(7,283) |
(105) |
|
|
Non-recurring Events |
|
Discontinued Operations |
– |
– |
– |
– |
|
Extraordinary Items |
– |
– |
– |
– |
|
Effect Of Accounting Changes |
– |
– |
– |
– |
|
Other Items |
– |
– |
– |
– |
|
|
| Net Income |
(1,125) |
(1,283) |
(7,283) |
(105) |
| Preferred Stock And Other Adjustments |
– |
– |
– |
– |
|
| Net Income Applicable To Common Shares |
(1,125) |
(1,283) |
(7,283) |
(105) |
|